237 related articles for article (PubMed ID: 35038644)
1. Immunopathogenesis of Behçet's disease and treatment modalities.
van der Houwen TB; van Hagen PM; van Laar JAM
Semin Arthritis Rheum; 2022 Feb; 52():151956. PubMed ID: 35038644
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive overview on the genetics of Behçet's disease.
Mahmoudi M; Aslani S; Meguro A; Akhtari M; Fatahi Y; Mizuki N; Shahram F
Int Rev Immunol; 2022; 41(2):84-106. PubMed ID: 33258398
[TBL] [Abstract][Full Text] [Related]
3. Behçet's Disease: A Comprehensive Review on the Role of
Khoshbakht S; Başkurt D; Vural A; Vural S
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003572
[TBL] [Abstract][Full Text] [Related]
4. Behçet's Disease: An Overview of Etiopathogenesis.
Leccese P; Alpsoy E
Front Immunol; 2019; 10():1067. PubMed ID: 31134098
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of Behçet's disease: autoinflammatory features and beyond.
Gül A
Semin Immunopathol; 2015 Jul; 37(4):413-8. PubMed ID: 26068404
[TBL] [Abstract][Full Text] [Related]
6. Genetics of Behçet's disease: lessons learned from genomewide association studies.
Gül A
Curr Opin Rheumatol; 2014 Jan; 26(1):56-63. PubMed ID: 24257369
[TBL] [Abstract][Full Text] [Related]
7. Behçet's disease: ocular effects and treatment.
Deuter CM; Kötter I; Wallace GR; Murray PI; Stübiger N; Zierhut M
Prog Retin Eye Res; 2008 Jan; 27(1):111-36. PubMed ID: 18035584
[TBL] [Abstract][Full Text] [Related]
8. Decoding Behcet's Uveitis: an In-depth review of pathogenesis and therapeutic advances.
Guan Y; Li F; Li N; Yang P
J Neuroinflammation; 2024 May; 21(1):133. PubMed ID: 38778397
[TBL] [Abstract][Full Text] [Related]
9. Behҫet's Disease, and the Role of TNF-α and TNF-α Blockers.
van der Houwen T; van Laar J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349254
[TBL] [Abstract][Full Text] [Related]
10. New insights into the pathogenesis of Behçet's disease.
Pineton de Chambrun M; Wechsler B; Geri G; Cacoub P; Saadoun D
Autoimmun Rev; 2012 Aug; 11(10):687-98. PubMed ID: 22197900
[TBL] [Abstract][Full Text] [Related]
11. Behçet's disease: An immunogenetic perspective.
Salmaninejad A; Zamani MR; Shabgah AG; Hosseini S; Mollaei F; Hosseini N; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8055-8074. PubMed ID: 30341905
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1.
Kirino Y; Bertsias G; Ishigatsubo Y; Mizuki N; Tugal-Tutkun I; Seyahi E; Ozyazgan Y; Sacli FS; Erer B; Inoko H; Emrence Z; Cakar A; Abaci N; Ustek D; Satorius C; Ueda A; Takeno M; Kim Y; Wood GM; Ombrello MJ; Meguro A; Gül A; Remmers EF; Kastner DL
Nat Genet; 2013 Feb; 45(2):202-7. PubMed ID: 23291587
[TBL] [Abstract][Full Text] [Related]
14. Current and future treatments for Behçet's uveitis: road to remission.
Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Dick AD; Adán A
Int Ophthalmol; 2014 Apr; 34(2):365-81. PubMed ID: 23729309
[TBL] [Abstract][Full Text] [Related]
15. The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.
Guasp P; Barnea E; González-Escribano MF; Jiménez-Reinoso A; Regueiro JR; Admon A; López de Castro JA
J Biol Chem; 2017 Jun; 292(23):9680-9689. PubMed ID: 28446606
[TBL] [Abstract][Full Text] [Related]
16. [Behçet's disease from the aspect of autoinflammatory disease].
Ishigatsubo Y; Samukawa S
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):408-19. PubMed ID: 22041429
[TBL] [Abstract][Full Text] [Related]
17. [Pathophysiology of Behçet's disease].
Houman MH; Bel Feki N
Rev Med Interne; 2014 Feb; 35(2):90-6. PubMed ID: 24210264
[TBL] [Abstract][Full Text] [Related]
18. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease.
Sugita S; Kawazoe Y; Imai A; Kawaguchi T; Horie S; Keino H; Takahashi M; Mochizuki M
J Immunol; 2013 Jun; 190(11):5799-808. PubMed ID: 23630362
[TBL] [Abstract][Full Text] [Related]
19. Immunopathogenesis of ocular Behçet's disease.
Park UC; Kim TW; Yu HG
J Immunol Res; 2014; 2014():653539. PubMed ID: 25061613
[TBL] [Abstract][Full Text] [Related]
20. Behçet's disease.
Hirohata S; Kikuchi H
Arthritis Res Ther; 2003; 5(3):139-46. PubMed ID: 12723980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
